Defined Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,577
Closed -$440K 107
2025
Q2
$440K Sell
1,577
-3
-0.2% -$850 0.27% 83
2025
Q1
$492K Buy
1,580
+52
+3% +$15.4K 0.33% 71
2024
Q4
$398K Sell
1,528
-7
-0.5% -$2.08K 0.26% 83
2024
Q3
$495K Buy
1,535
+11
+0.7% +$3.6K 0.32% 67
2024
Q2
$476K Buy
1,524
+12
+0.8% +$3.52K 0.33% 71
2024
Q1
$430K Sell
1,512
-1
-0.1% -$293 0.31% 76
2023
Q4
$436K Buy
1,513
+5
+0.3% +$1.36K 0.33% 75
2023
Q3
$405K Buy
1,508
+16
+1% +$3.99K 0.35% 71
2023
Q2
$331K Buy
1,492
+2
+0.1% +$464 0.28% 82
2023
Q1
$360K Hold
1,490
0.34% 75
2022
Q4
$391K Sell
1,490
-190
-11% -$50.9K 0.37% 71
2022
Q3
$379K Hold
1,680
0.41% 63
2022
Q2
$409K Hold
1,680
0.42% 61
2022
Q1
$406K Hold
1,680
0.36% 66
2021
Q4
$378K Sell
1,680
-202
-11% -$42.6K 0.31% 68
2021
Q3
$400K Hold
1,882
0.35% 63
2021
Q2
$459K Hold
1,882
0.41% 55
2021
Q1
$468K Hold
1,882
0.44% 50
2020
Q4
$433K Buy
+1,882
New +$434K 0.43% 54

Other funds holding AMGN

Defined Wealth Management's AMGN Position: Q3 2025 in Review

Defined Wealth Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 1,577 shares — an estimated $440K sold.

Defined Wealth Management first reported a position in AMGN in Q4 2020 and held it in 19 quarters. The position peaked at $495K in Q3 2024. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Defined Wealth Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Defined Wealth Management sold 1,577 Amgen shares in Q3 2025, an estimated $440K.
  • Defined Wealth Management first reported a position in Amgen in Q4 2020 and held it in 19 quarters.
  • Defined Wealth Management's Amgen position peaked at $495K in Q3 2024.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Defined Wealth Management's 13F filing for Q3 2025, filed 7 Oct 2025.